Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Quoix

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Revue Des Maladies Respiratoires|April 3, 2010
[Small cell lung cancer and anti-Hu syndrome]N Prim, B Mennecier, C Behr, et al.
Revue De Pneumologie Clinique|April 21, 2009
[First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma]M Burgin, A -C Gairard-Dory, B Mennecier, et al.
Chest|May 1, 1995
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureM Oswald-Mammosser, E Weitzenblum, E Quoix, et al.
Revue De Pneumologie Clinique|January 1, 1994
[Multiple nodular opacities]P Schinkewitch-Sorbier, E Popin, A Baturalp, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2015
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)L Biganzoli, S Lichtman, J-P Michel, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesotheliomaA Purohit, L Moreau, A Dietemann, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancerD Levêque, E Quoix, P Dumont, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Can we predict very short term survival in small cell lung cancer?E Quoix, G Hedelin, E Popin, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Imaging of non-small-cell pulmonary tumors. Therapeutic strategy]A Gangi, M Y Jeung, D Pfleger, et al.
Revue De Pneumologie Clinique|January 1, 1992
[A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial]A Depierre, C Chastang, B Lebeau, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Revue Des Maladies Respiratoires|April 3, 2010
[Small cell lung cancer and anti-Hu syndrome]N Prim, B Mennecier, C Behr, et al.
Revue De Pneumologie Clinique|April 21, 2009
[First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma]M Burgin, A -C Gairard-Dory, B Mennecier, et al.
Chest|May 1, 1995
Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureM Oswald-Mammosser, E Weitzenblum, E Quoix, et al.
Revue De Pneumologie Clinique|January 1, 1994
[Multiple nodular opacities]P Schinkewitch-Sorbier, E Popin, A Baturalp, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2015
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)L Biganzoli, S Lichtman, J-P Michel, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesotheliomaA Purohit, L Moreau, A Dietemann, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancerD Levêque, E Quoix, P Dumont, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1993
Can we predict very short term survival in small cell lung cancer?E Quoix, G Hedelin, E Popin, et al.
Revue Des Maladies Respiratoires|August 5, 1998
[Imaging of non-small-cell pulmonary tumors. Therapeutic strategy]A Gangi, M Y Jeung, D Pfleger, et al.
Revue De Pneumologie Clinique|January 1, 1992
[A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial]A Depierre, C Chastang, B Lebeau, et al.
Pageof 16